Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AdvisorShares Pure US Cannabis ETF MSOS

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in... see more

ARCA:MSOS - Post Discussion

AdvisorShares Pure US Cannabis ETF > MSOS and Rare Cannabinoids
View:
Post by Bullknit101 on Nov 17, 2021 12:08pm

MSOS and Rare Cannabinoids

It's about time for breakout. InMed will be the go to address for minor cannabinoids to supply MSOs and big pharma who want to get going with Cnanabinoid clinical trials. https://finance.yahoo.com/quote/INM/
Comment by mikeL2021 on Nov 18, 2021 11:37pm
No, the legalization on federal level won't happen anytime soon.  it's unlikely any act will pass due to the divine in the democrats.   Nothing will have a breakout soon
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities